Back to search results
NCT03623672

North American Prodromal Synucleinopathy Consortium

Enrolling by Invitation
Not specifiedAges 18+Observational
Washington University School of Medicine
~500 participants
Updated 2024-11-06 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 10 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Prodromal Synucleinopathy Rating Scale
Measured over 2 years

Conditions

REM Sleep Behavior Disorder
Parkinson Disease
Lewy Body Disease
Dementia With Lewy Bodies
Multiple System Atrophy
REM Sleep Parasomnias

Explore related trials

REM sleep behavior disorder

NCT03623672

Where you'd take part

This study runs at 10 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Banner Sun Health Research Institute

    Sun City, Arizonano site contact published

  • Emory University

    Atlanta, Georgiano site contact published

  • Massachusetts General Hospital

    Boston, Massachusettsno site contact published

  • Mayo Clinic

    Rochester, Minnesotano site contact published

  • McGill University

    Montreal, Quebec, Canadano site contact published

  • Portland VA Medical Center

    Portland, Oregonno site contact published

  • Stanford University

    Redwood City, Californiano site contact published

  • University of California Los Angeles

    Los Angeles, Californiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Yo-El Ju, MD · PRINCIPAL_INVESTIGATOR · Washington University School of Medicine
  • Bradley Boeve, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Idiopathic REM sleep behavior disorder

Exclusion

REM sleep behavior disorder secondary to another cause (ex: narcolepsy, dementia, Parkinson's Disease, etc)
Other neurological disorder

What this trial measures

  • Prodromal Synucleinopathy Rating Scale2 years

    Rating scale combining neurocognitive battery, motor, autonomic, olfaction, color vision functions. Global score range 0-3, with higher score indicating greater symptoms of synucleinopathy.